- Home
- Meeting Real-world Challenges in Hypercholesterolaemia Management: Insight from a Pan-European Crowdsourcing Activity
Meeting Real-world Challenges in Hypercholesterolaemia Management: Insight from a Pan-European Crowdsourcing Activity
- MI/ACS
Available Credit:
- 1.00 European Board for Accreditation in Cardiology (EBAC)
Course Published On:
Course Expiry Date:
Overview
In compliance with ISCP guidelines, all speakers/chair persons participating in this programme have disclosed or indicated potential conflicts of interest which might cause a bias in the presentations. The Organising Committee/Course Director is responsible for ensuring that all potential conflicts of interest relevant to the event are declared to the audience prior to the CME activities. This programme is supported by an unrestricted educational grant from Novartis.
The Organising Committee/Course Director is responsible for ensuring that all potential conflicts of interest relevant to the event are declared to the audience prior to the CME activities.
Disclosure
Radcliffe Education requires contributors to our CME programmes to disclose any relevant financial relationships that have occurred within the past 12 months that could create a conflict of interest. These will be identified in the faculty section if applicable.
The session, ‘Meeting Real-world Challenges in Hypercholesterolaemia Management: Insight from a Pan-European Crowdsourcing Activity’ is accredited by the International Society of Cardiovascular Pharmacotherapy (ISCP) for 1 hour of external CME credits.
Each participant should claim only those hours of credit that have actually been spent in the educational activity.
Instructions to participants
There is no fee for taking part in this online learning activity.
Activities are designed to be completed within 60 minutes and must be completed by the registered user. Physicians should only claim credits for time spent on the activity. To successfully earn credit, participants must complete the activity in full in the indicated time frame.
To complete the course and claim certification participants must:
- Read the course outline information supplied and complete pre-test questions if supplied prior to starting the activity. Users must read and study the activity in its entirety before completing the post-test questions.
- Your results will be automatically saved and if a pass score is achieved (where applicable), you may be eligible to claim credit for the activity and receive a certificate of completion.
Target Audience
This programme is intended to educate:
- General Cardiologists
- Preventative Cardiologists
- Primary Care Physicians
Learning Objectives
The overall programme, 'Meeting Real-world Challenges in Hypercholesterolaemia Management: Insight from a Pan-European Crowdsourcing Activity' endeavours to best address the following learning objectives:
- Discuss the current practice gaps in hypercholesterolaemia management
- Recall best practice for assessing CV risk, defining LDL-C targets and offering patient education
- Stratify patients by CV risk category
- Select cholesterol-lowering therapies according to risk category and LDL-C target
Module |
Title |
Duration |
Speakers |
|---|---|---|---|
| Welcome | Welcome and introduction | Lale Tokgozoglu | |
| Session 1 | Current knowledge and practice gaps in hypercholesterolaemia | Kausik Ray | |
| Session 2 | Further insight into physician and patient behaviour | Yassir Javaid | |
| Session 3 | Addressing knowledge gaps in hypercholesterolaemia management | Maciej Banach | |
| Session 4 | Discussion / Live Q&A | Lale Tokgozoglu Maciej Banach Kausik Ray Yassir Javaid |
- 1.00 European Board for Accreditation in Cardiology (EBAC)
Related Courses
- 1.00 EBAC
Published:
Learning objectives
- Recall the components of the ‘ominous octet’ & how they contribute to T2DM development
- Identify underlying facets of clinical inertia in T2DM care
- Describe how early adoption of intensive glycaemic control leads to better outcomes in T2DM
- Recall efficacy & the mode of action of various incretin-based treatments
- Adopt an early, intensive glucose-lowering strategy in appropriate individuals
- Select appropriate incretin treatment & dosing regimens according to patient profiles
- Identify individuals likely to gain cardiovascular benefit from GLP-1RAs
- Select appropriate actions following adverse events from incretin-based treatments
- 1.00 EBAC
Published:
Learning objectives
- Recall the supportive evidence underpinning recommended antiplatelet approaches in individuals with unknown coronary anatomy, including choice of therapy, duration, timing and loading doses
- Compare the design of different clinical trials that have influenced antiplatelet therapy choice in NSTE-ACS patients who proceed to PCI
- Apply trial data and clinical guidelines on the use of antiplatelet therapy in patients undergoing revascularisation to a surrogate patient case
- 1.00 EBAC
Published:
Learning objectives
- Evaluate emerging clinical data related to interventional cardiology practice including for both devices and pharmacology
- Recognise the latest interventional approaches for SHD and Complex PCI available for the optimal management of CV patients
- Assess the merits of adopting emerging technologies within their practice
- Apply the practical guidance to maximise success of their interventional procedures within TAVR, Mitral & Tricuspid Valve Replacement and Complex PCIs
- Interact with opinion leaders in their profession
- 1.00 EBAC
Published:
Learning objectives
- Evaluate emerging clinical data related to interventional cardiology practice including for both devices and pharmacology
- Recognise the latest interventional approaches for SHD and Complex PCI available for the optimal management of CV patients
- Assess the merits of adopting emerging technologies within their practice
- Apply the practical guidance to maximise success of their interventional procedures within TAVR, Mitral & Tricuspid Valve Replacement and Complex PCIs
- Interact with opinion leaders in their profession
- 1.00 EBAC
Published:
Learning objectives
- Evaluate emerging clinical data related to interventional cardiology practice including for both devices and pharmacology
- Recognise the latest interventional approaches for SHD and Complex PCI available for the optimal management of CV patients
- Assess the merits of adopting emerging technologies within their practice
- Apply the practical guidance to maximise success of their interventional procedures within TAVR, Mitral & Tricuspid Valve Replacement and Complex PCIs
- Interact with opinion leaders in their profession
- 1.00 EBAC
Published:
Learning objectives
- Evaluate emerging clinical data related to interventional cardiology practice including for both devices and pharmacology
- Recognise the latest interventional approaches for SHD and Complex PCI available for the optimal management of CV patients
- Assess the merits of adopting emerging technologies within their practice
- Apply the practical guidance to maximise success of their interventional procedures within TAVR, Mitral & Tricuspid Valve Replacement and Complex PCIs
- Interact with opinion leaders in their profession
- 1.00 EBAC
Published:
Learning objectives
- Evaluate emerging clinical data related to interventional cardiology practice including for both devices and pharmacology
- Recognise the latest interventional approaches for SHD and Complex PCI available for the optimal management of CV patients
- Assess the merits of adopting emerging technologies within their practice
- Apply the practical guidance to maximise success of their interventional procedures within TAVR, Mitral & Tricuspid Valve Replacement and Complex PCIs
- Interact with opinion leaders in their profession
- 1.00 EBAC
Published:
Learning objectives
- Evaluate emerging clinical data related to interventional cardiology practice including for both devices and pharmacology
- Recognise the latest interventional approaches for SHD and Complex PCI available for the optimal management of CV patients
- Assess the merits of adopting emerging technologies within their practice
- Apply the practical guidance to maximise success of their interventional procedures within TAVR, Mitral & Tricuspid Valve Replacement and Complex PCIs
- Interact with opinion leaders in their profession
- 1.00 EBAC
Published:
Learning objectives
- Evaluate emerging clinical data related to interventional cardiology practice including for both devices and pharmacology
- Recognise the latest interventional approaches for SHD and Complex PCI available for the optimal management of CV patients
- Assess the merits of adopting emerging technologies within their practice
- Apply the practical guidance to maximise success of their interventional procedures within TAVR, Mitral & Tricuspid Valve Replacement and Complex PCIs
- Interact with opinion leaders in their profession